Home > Boards > US Listed > Medical - Drugs >

Merck & Co. Inc. (MRK)

MRK RSS Feed
Add MRK Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 11/23/2020 8:38:53 AM - Followers: 46 - Board type: Free - Posts Today: 0
MRK
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRK News: Merck Animal Health Survey Reveals First-Time Dog Owners Need Support 11/23/2020 09:06:00 AM
MRK News: Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine, f... 11/23/2020 06:47:00 AM
MRK News: Merck to Acquire OncoImmune 11/23/2020 06:45:00 AM
MRK News: Merck Announces First-Quarter 2021 Dividend 11/17/2020 01:25:00 PM
MRK News: Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acqu... 11/16/2020 06:45:00 AM
PostSubject
#508  Sticky Note Spinoff of women’s health/off-patent brands/biosimilars into new (as DewDiligence 02/05/20 08:20:57 AM
#575   MRK submits BLA/MAA for V114 pneumococcal vaccine in adults: DewDiligence 11/23/20 08:38:53 AM
#574   MRK acquires—(private)—Oncoimmune for $425M cash plus contingent payments: DewDiligence 11/23/20 08:34:35 AM
#573   Merck Announces First-Quarter 2021 Dividend FUNMAN 11/17/20 01:56:39 PM
#572   FDA_approves_Keytruda/chemo_ in_1L-metastatic_or locally_recurrent_TNBC_with_PD- DewDiligence 11/13/20 05:43:34 PM
#571   Keytruda+Yervoy_not_better_than_Keytruda_monotherapy_in_1L-NSCLC with PD-L1>=50% DewDiligence 11/09/20 06:46:58 PM
#570   MRK acquires—(private)—VelosBio_for_$2.75B cash: DewDiligence 11/05/20 08:24:41 AM
#569   PFE shareholders who swapped their shares for ZTS DewDiligence 11/03/20 10:34:56 AM
#568   PFE spun $ZTS and the rest is history Seeker213 11/03/20 10:31:54 AM
#567   Animal-health is MRK’s fastest growing division, which is DewDiligence 11/03/20 09:30:30 AM
#566   Spin off the pet meds and reward your Seeker213 11/03/20 05:52:34 AM
#565   MRK 3Q20 results—non-GAAP EPS guidance raised… DewDiligence 10/27/20 11:38:48 AM
#564   V114—MRK’s 15-valent pneumococcal vaccine—meets primary endpoint in two DewDiligence 10/20/20 10:53:52 AM
#563   FDA approves Keytruda monotherapy for rrcHL, based on DewDiligence 10/15/20 11:54:50 AM
#562   MRK’s Roger Perlmutter retires effective at year-end: DewDiligence 10/02/20 11:10:27 AM
#561   MRK’s ESMO slides: DewDiligence 09/22/20 11:15:42 AM
#559   MRK’s ESMO data for early-stage pipeline—Vibostolimab/MK-7684 (anti-TIGIT); MK-4830 DewDiligence 09/20/20 01:47:05 PM
#558   Keytruda monotherapy in adjuvant-melanoma—>statsig DMFS* benefit @3.5 years: DewDiligence 09/19/20 12:15:32 PM
#557   MRK, SGEN ink global development/commercialization deal for Ladiratuzumab Vedoti DewDiligence 09/14/20 09:37:21 AM
#556   V114—MRK’s 15-valent pneumococcal vaccine—meets primary endpoint in phase-3 DewDiligence 09/09/20 10:49:05 AM
#555   Merck & Co. Inc should buyout MYMX (Mymetics) bow-tie 09/03/20 12:04:42 AM
#554   Article mentioning Merck & Co. Nfixus 08/31/20 03:55:59 PM
#553   Keytruda/chemo shows statsig-superior OS vs chemo alone in DewDiligence 08/19/20 10:55:40 AM
#552   Barron’s like MRK—for both valuation and COVID-19 opportunity: DewDiligence 08/15/20 03:34:29 PM
#550   MRK enters the NASH arena: DewDiligence 08/04/20 11:34:54 AM
#549   News: $MRK Merck & Co. (MRK) Q2 2020 whytestocks 08/01/20 08:45:34 AM
#548   MRK 2Q20 items… DewDiligence 07/31/20 09:10:29 AM
#547   Vericiguat/heart-failure PDUFA—>1/20/21 (with FDA priority review): DewDiligence 07/16/20 10:14:44 AM
#546   Keytruda monotherapy BLA in rrcHL—>10/30/20 PDUFA (with FDA DewDiligence 07/09/20 09:49:13 AM
#545   MRK, Eisai receive CRL for Keytruda/Lenvima in 1L-HCC: DewDiligence 07/08/20 11:02:50 AM
#544   FDA approves Keytruda monotherapy in 1L-MSI-H/dMMR CRC, converting DewDiligence 06/29/20 04:16:08 PM
#543   FDA approves Keytruda monotherapy in cSCC: DewDiligence 06/25/20 01:09:32 PM
#541   FDA approves Keytruda monotherapy for TMB-high solid tumors DewDiligence 06/17/20 11:04:12 AM
#540   MRK - jeffp123 06/17/20 09:02:13 AM
#539   MRK sells $4.5B of 5-30yr notes: DewDiligence 06/16/20 05:36:48 PM
#538   Is Mrk buying NWBO jdheart101 06/15/20 02:52:14 PM
#537   Superb news on the expansion. I’m going to grich1 06/14/20 11:42:42 AM
#536   FDA expands Gardasil label to include prevention of DewDiligence 06/12/20 07:03:47 PM
#535   Keytruda misses phase-3 primary endpoint in bladder cancer DewDiligence 06/09/20 05:26:26 PM
#534   Stay long, get slaughtered! All FDA approvals will Lowjack 06/05/20 03:16:15 AM
#533   FDA approves MRK’s Recarbrio (a combination of three DewDiligence 06/04/20 11:15:26 PM
#532   Merck is relatively cheap with a p/e multiple LionsTact 05/26/20 09:08:09 PM
#531   MRK goes all-in on COVID-19 with three deals… DewDiligence 05/26/20 09:43:28 AM
#530   FDA approves Lynparza in second-line CRPC with HRR mutations: DewDiligence 05/20/20 01:29:23 PM
#529   MRK’s women’s-health/branded-generics/biosimilars spin-off will be called…Organo DewDiligence 04/28/20 10:05:16 PM
#528   FDA approves q6w dosing for Keytruda monotherapy indications: DewDiligence 04/28/20 05:14:15 PM
#527   MRK cuts 2020 guidance due to heavy reliance DewDiligence 04/28/20 03:15:47 PM
#526   MRK/AZN—Lynparza shows statsig-superior OS to hormonal agents (Xtandi, DewDiligence 04/24/20 12:51:00 PM
#525   Your prescience is acknowledged. Nice. Trueheart 04/23/20 12:10:19 PM
#524   I bought MRK in 2013 (#msg-88261837). DewDiligence 04/22/20 10:23:52 AM
#523   I'm not. I got in at $80. Trueheart 04/22/20 02:11:24 AM
PostSubject
Consent Preferences